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Abstract 
Neuregulins, with the exception of neuregulin-4 (NRG4), have been shown to be 
extensively involved in many aspects of neural development and function and are implicated in 
several neurological disorders, including schizophrenia, depression and bipolar disorder.  Here 
we provide the first evidence that NRG4 has a crucial function in the developing brain.  We 
show that both the apical and basal dendrites of neocortical pyramidal neurons are markedly 
stunted in Nrg4
-/-
 neonates in vivo compared with Nrg4
+/+
 littermates. Neocortical pyramidal 
neurons cultured from Nrg4
-/-
 embryos had significantly shorter and less branched neurites than 
those cultured from Nrg4
+/+
 littermates.  Recombinant NRG4 rescued the stunted phenotype of 
embryonic neocortical pyramidal neurons cultured from Nrg4
-/-
 mice.  The majority of cultured 
wild type embryonic cortical pyramidal neurons co-expressed NRG4 and its receptor ErbB4. The 
difference between neocortical pyramidal dendrites of Nrg4
-/-
 and Nrg4
+/+
 mice was less 
pronounced, though still significant, in juvenile mice.  However, by adult stages, the pyramidal 
dendrite arbors of Nrg4
-/-
 and Nrg4
+/+
 mice were similar, suggesting that compensatory changes 
in Nrg4
-/-
 mice occur with age.  Our findings show that NRG4 is a major novel regulator of 
dendritic arborisation in the developing cerebral cortex and suggest that it exerts its effects by an 
autocrine/paracrine mechanism. 
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1. Introduction 
The neuregulins are widely expressed pleiotropic growth factors related to epidermal 
growth factor that signal via the ErbB family of receptor tyrosine kinases (Britsch, 2007). Very 
extensive work on the first neuregulin discovered (NRG1), has revealed that its numerous 
isoforms play many roles in the development and function of neurons and glia, including 
regulating the assembly of neural circuitry, myelination, neurotransmission and synaptic 
plasticity (Mei and Nave, 2014).  Likewise, numerous studies on NRG2 and NRG3 have 
revealed that they participate in synaptogenesis, synaptic function and aspects of neuronal 
development (Bartolini et al., 2017; Lee et al., 2015; Vullhorst et al., 2015). Importantly, the 
Nrg1, Nrg2, Nrg3, ErbB3 and ErbB4 genes have been identified as susceptibility genes for 
schizophrenia, depression and bipolar disorder (Mei and Nave, 2014; Rico and Marin, 2011) and 
numerous genetic and functional studies have directly implicated the Nrg1, Nrg2, Nrg3 and 
ErbB4 genes in the development of psychotic behaviour (Hayes et al., 2016; O'Tuathaigh et al., 
2007, 2010; Shamir et al., 2012; Yan et al., 2017). Although much less work has been done on 
the latest neuregulins to be identified, NRG5 and NRG6, both are highly expressed in brain 
(Kanemoto et al., 2001; Kinugasa et al., 2004). NR6 plays a role in radial neuronal migration in 
the neocortex (Zhang et al., 2013) and is a potential susceptibility gene for schizophrenia (So et 
al., 2010). 
In contrast with other neuregulins, NRG4 is expressed in a limited number of adult 
tissues, such as brown adipose tissue, and has been reported to have no or negligible expression 
in adult brain (Harari et al., 1999; Rosell et al., 2014).  NRG4 functions as a secreted endocrine 
factor in vivo produced and released by brown adipose tissue.  NRG4 decreases hepatic 
lipogenesis, increases fatty acid -oxidation and increases energy expenditure (Chen et al., 2017; 
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Wang et al., 2014).  While NRG4 has been implicated in the regulation of metabolic homeostasis, 
it has no known function in the brain.  Our analysis of mice in which the Nrg4 locus has been 
disrupted reveals a very striking phenotype in neocortical pyramidal neurons both in vitro and in 
vivo. As such, we provide the first evidence that NRG4 plays a major role in the brain. 
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2. Materials and methods 
 
2.1. Animals  
Mice were housed in a 12h light-dark cycle with access to food and water ad libitum.  
Breeding was approved by the Cardiff University Ethical Review Board and was performed 
within the guidelines of the Home Office Animals (Scientific Procedures) Act, 1986.  Nrg4 null 
mice in which the Nrg4 locus was disrupted by retroviral insertion of a gene trap between exons 
1 and 2 were purchased from the Mutant Mouse Resource Centre, UC Davis (California, USA).  
These mice were backcrossed from a C57/BL6 background into a CD1 background. Nrg4
+/- 
mice 
were crossed to generate Nrg4
+/+
 and Nrg4
-/-
 littermates.  
 
2.2. Neuron culture 
Primary cortical neurons were prepared from E16 embryos. The protocol for culturing 
hippocampal pyramidal neurons was used with modifications (Kaech and Banker, 2006). Briefly, 
dissected cortices were mechanically triturated in Neurobasal A medium supplemented with 2% 
B27 (Gibco), 0.5 mM GlutaMAX 1, 100 units/ml penicillin and 100 μg/ml streptomycin 
(Invitrogen). 15,000 cells/cm
2
 were plated on poly-L-Lysine (Sigma)-coated 35 mm dishes and 
incubated at 37°C in a humidified atmosphere with 5% CO2. In some cultures, the culture 
medium was supplemented with 100 ng/ml recombinant NRG4 (Thermo Fisher Scientific) after 
plating.  Neurons were cultured for either 3 or 9 days in vitro.  Neurons were fluorescently 
labelled in 3 day cultures by treating the cultures with the fluorescent dye calcein-AM (2 μg/ml, 
Invitrogen) for 15 min at 37°C. In 9 days cultures, the neurite arbors of a subset of the neurons 
were visualised by transfecting the neurons with a GFP expression plasmid using lipofectamine 
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2000 (Invitrogen, Paisley, UK) after 7 days in vitro. Briefly, 1 g of DNA was mixed with 2 l 
of lipofectamine.  After 20 min, this mixture in 2 ml of Opti-MEM media (Gibco) was added to 
the cultures. After 3 h at 37°C, the cultures were washed with culture medium and incubated for 
a further 2 days. At the end of the experiment, the neurons were fixed for 30 min with 4% 
paraformaldehyde.  Images of fluorescent-labelled neurons were acquired with an Axiovert 200 
Zeiss fluorescent microscope. Neurite length and Sholl analysis were carried out using Fiji 
(ImageJ) software with the semi-automated plugin Simple Neurite Tracer (Longair et al., 2011).  
 
2.3. Immunohistochemistry 
Brains were fixed overnight using 4% paraformaldehyde in 0.12 M phosphate-buffered 
saline (PBS) at 4°C, washed in PBS and cryoprotected in 30% sucrose before being frozen in dry 
ice-cooled isopentane. Serial 30 μm sections were blocked in 1% BSA (Sigma), 0.1% Triton 
(Sigma) in PBS and then incubated with 1:500 anti-MAP2 (Millipore) and anti-NRG4 (Abcam) 
antibodies at 4°C overnight. After washing, the sections were incubated with 1:500 rabbit 
polyclonal Alexa-conjugated secondary antibodies (Invitrogen) for 1 h at room temperature. 
Sections were washed, incubated with DAPI and visualized using a Zeiss LSM710 confocal 
microscope.  
 
2.4. Immunocytochemistry 
Neurons were fixed for 10 mins in 4% paraformaldehyde in 0.12 M phosphate-buffered 
saline (PBS), washed 3 times in PBS and blocked in 1% BSA (Sigma), 0.1% Triton (Sigma) in 
PBS for 1 hr, then incubated with primary antibodies (1:50) against NRG4 (Santa Cruz), ErbB4 
(Abcam), Emx1 (Santa Cruz) overnight at 4°C. After washing, the neurons were incubated with 
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polyclonal Alexa-conjugated secondary antibodies (Invitrogen) 1:500 for 1 h at room 
temperature. Cells were then washed, incubated with DAPI (1:8000) and visualized using a Zeiss 
LSM710 confocal microscope.  
 
2.5. Quantitative PCR 
The levels of Nrg4 mRNA was quantified by RT-qPCR relative to a geometric mean of 
mRNAs for the house keeping enzymes glyceraldehyde phosphate dehydrogenase (Gapdh), 
succinate dehydrogenase (Sdha) and hypoxanthine phosphoribosyltransferase-1 (Hprt1).  Total 
RNA was extracted from dissected tissues with the RNeasy Mini Lipid extraction kit (Qiagen, 
Crawely, UK). 5 μl total RNA was reverse transcribed, for 1 h at 45°C, using the Affinity Script 
kit (Agilent, Berkshire, UK) in a 25 µl reaction according to the manufacturer’s instructions. 2 µl 
of cDNA was amplified in a 20 µl reaction volume using Brilliant III ultrafast qPCR master mix 
reagents (Agilent Technologies). PCR products were detected using dual-labelled (FAM/BHQ1) 
hybridization probes specific to each of the cDNAs (MWG/Eurofins, Ebersberg, Germany). The 
PCR primers were: Nrg4 forward: 5′-GAG ACA AAC AAT ACC AGA AC-3′  and reverse: 5′-
GGA CTG CCA TAG AAA TGA-3′; ErbB4 forward: 5′-GGC AAT ATC TAC ATC ACT G-3′ 
and reverse: 5′-CCA ACA ACC ATC ATT TGA A-3′; Gapdh forward: 5′-GAG AAA CCT 
GCC AAG TAT G-3′ and reverse: 5′-GGA GTT GCT GTT GAA GTC-3′; Sdha forward: 5′-
GGA ACA CTC CAA AAA CAG-3′ and reverse: 5′-CCA CAG CAT CAA ATT CAT-3′; Hprt1 
forward: 5′-TTA AGC AGT ACA GCC CCA AAA TG-3′ and reverse: 5′-AAG TCT GGC CTG 
TAT CCA ACA C-3′. Dual-labelled probes were: Nrg4: 5′-FAM-CGT CAC AGC CAC AGA 
GAA CAC-BHQ1-3′; ErbB4: 5′-FAM-AGC AAC CTG TGT TAT TAC CAT ACC ATT-
BHQ1-3′; Gapdh: 5′-FAM-AGA CAA CCT GGT CCT CAG TGT-BHQ1-3; Sdha: 5′-FAM-
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CCT GCG GCT TTC ACT TCT CT-BHQ1-3, Hrpt1: 5′-FAM-TCG AGA GGT CCT TTT CAC 
CAG CAA G-BHQ1-3′. Forward and reverse primers were used at a concentration of 250 nM 
and dual-labelled probes were used at a concentration of 500 nM. PCR was performed using the 
Mx3000P platform (Agilent) using the following conditions: 95°C for 3 minutes followed by 45 
cycles of 95°C for 10 seconds and 60°C for 35 seconds. Standard curves were generated for each 
cDNA for every real time PCR run, by using serial threefold dilutions of reverse transcribed 
adult mouse brain total RNA (Zyagen, San Diego, USA). Relative mRNA levels were quantified 
in whole brain, BAT and various brain regions dissected from at least 3 animals at each age. 
Primer and probe sequences were designed using Beacon Designer software (Premier Biosoft, 
Palo Alto, USA). 
 
2.6. Golgi staining  
Modified Golgi-Cox impregnation of neurons was performed using the FD Rapid 
GolgiStain kit (FD NeuroTechnologies) according to the manufacturer’s instructions on 150 m 
transverse sections of P10, P30 and adult (P60 and P70) brains of Nrg4
+/+
 and Nrg4
-/-
 mice. Total 
dendrite length, branch point number and Sholl analysis was carried out separately on the apical 
and basal dendrite compartments of cortical pyramidal neurons of P10 and P30 littermates using 
the plugin Sholl Analysis of Fiji software (Schindelin et al., 2012) after neuronal reconstruction 
with the plugin Simple Neurite Tracer (Longair et al., 2011). 
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3. Results and Discussion 
 
3.1. Expression of Nrg4 transcripts in developing brain 
To begin to explore the possibility that NRG4 functions in the developing brain, we used 
qPCR to investigate if Nrg4 mRNA is expressed in the embryonic mouse neocortex.  This 
revealed that Nrg4 mRNA is clearly detectable in the embryonic neocortex, although its level is 
some 400-fold lower than that in adult brown adipose tissue. During development, there is an 
approximate 3-fold increase between E14 and birth (Fig. 1A).  Measurement of Nrg4 mRNA in 
newborn brain regions revealed that Nrg4 mRNA is widely expressed, with the highest levels in 
the cerebellum and olfactory bulb (Fig. 1B).  Measurement of ErbB4 mRNA, which encodes the 
receptor for most neuregulins, including NRG4, revealed that this is also widely expressed in the 
newborn brain, with the highest levels in the neocortex (Fig. 1C). 
 
3.2. Neocortical pyramidal dendrites are markedly stunted in neonatal Nrg4-/- mice 
To investigate the significance of Ngr4 mRNA expression in the developing brain, we 
compared the brains of Nrg4
-/-
 and Nrg4
+/+
 mice. Golgi preparations of transverse sections were 
made of the most rostral part of the neocortex, including the frontal/motor cortex and the most 
rostral region of the somatosensory cortex of postnatal day 10 (P10) mice.  These revealed that 
the size and complexity of the dendritic arbors of pyramidal neurons throughout the full 
thickness of the neocortex were dramatically reduced in Nrg4
-/-
 mice compared with Nrg4
+/+
 
littermates. Representative high power images show that the reduction of dendrite size and 
complexity in Nrg4
-/-
 mice affected both apical and basal dendrite compartments of these 
neurons (Fig. 2A).  Analysis carried out separately on the apical and basal dendrite 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 
 
10 
compartments revealed a highly significant four-fold reduction in total dendrite length (Fig. 2B) 
and a significant two-fold reduction in the number of branch points (Fig. 2C) in both dendrite 
compartments. Reductions in dendrite length and branching were reflected in the Sholl analyses 
of apical (Fig. 2D) and basal (Fig. 2E) compartments.  These findings suggest that NRG4 plays a 
major and unexpected role in promoting the growth and elaboration of pyramidal neuron 
dendrites in the developing neocortex.   
 
3.3. The pyramidal dendrite phenotype in Nrg4-/- mice becomes less marked with age 
To determine whether the pronounced phenotype observed in neonatal Nrg4
-/-
 mice is 
retained into adulthood or whether compensatory changes occur with age, we repeated the Golgi 
studies in juvenile (P30) and adult (P60 and P70) littermates.  In P30 mice, the difference in the 
size and complexity of neocortical pyramidal dendrites between Nrg4
+/+
 and Nrg4
-/-
 mice was 
still evident, though less pronounced than in neonates (Fig 3A).  Quantification confirmed this 
impression, and showed that both the apical and basal dendrites of neocortical pyramidal neurons 
of P30 Nrg4
-/-
 mice were shorter and less branched than those of Nrg4
+/+
 littermates (Figs. 3B 
and 3C). Compared with P10 preparations, the proportional differences in dendrite length and 
branching between Nrg4
-/-
 and Nrg4
+/+
 mice were less pronounced. While the differences were 
still highly significant for apical dendrites, they had lost statistical significance for basal 
dendrites by this age.  The differences in apical and basal dendrite length and branching between 
Nrg4
-/-
 and Nrg4
+/+
 mice were reflected in the Sholl analyses of apical (Fig. 3D) and basal (Fig. 
3E) compartments. In adult mice (P60 and P70) there did not appear to be pronounced 
differences in the size and complexity of neocortical pyramidal dendrite arbors of Nrg4
-/-
 and 
Nrg4
+/+
 mice (Fig. 4). However, the large size and complexity of neocortical pyramidal dendrites 
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in adults precluded accurate quantification.  Taken together, these findings suggest that 
compensatory changes in the pyramidal dendrites of Nrg4
-/-
 mice occur with age.  This may be 
mediated by other members of neuregulin family, which are expressed at high levels in the 
mature brain. 
Various phenotypic changes have been reported in neurons in genetic studies of other 
neuregulins and ErbB receptors.  Although constitutive deletion of the Nrg1, ErbB2 and ErbB4 
genes results in embryonic lethality, conditional deletion of ErbB2/B4 in the brain decreases 
pyramidal neuron dendritic spine maturation in the cortex and hippocampus without affecting the 
gross dendrite morphology (Barros et al., 2009).  Spine density is significantly reduced in 
cortical pyramidal neurons when ErbB4 is conditionally deleted in these neurons (Cooper and 
Koleske, 2014) and synaptic spine size and density is likewise reduced in CA1 hippocampal 
pyramidal neurons by RNAi knockdown of ErbB4 in these neurons (Li et al., 2007).  While 
impaired dendritic spine formation has not been consistently observed following ErbB4 deletion 
in pyramidal neurons (Fazzari et al., 2010; Yin et al., 2013), deletion of ErbB4 in parvalbumin-
positive GABAergic interneurons results in reduced spine density on hippocampal pyramidal 
neurons (Yin et al., 2013). Decreased dendritic spine density and impaired growth and 
elaboration of the basal dendrites of cortical pyramidal neurons have been reported in mice with 
targeted disruption of type III Nrg1 (Chen et al., 2008, 2010a).  Retroviral knockdown of Nrg2 in 
granule cells impairs dendrite growth and branching from these neurons in vivo (Lee et al., 2015). 
As well as interfering with the growth and elaboration of cortical pyramidal dendrites, in 
further work it will be interesting to ascertain whether deletion of Nrg4 affects dendrite spine 
density and maturation and the functional properties of synapses. Moreover, we focused on 
neocortical pyramidal neurons in our current study.  Given the widespread expression of Nrg4 
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mRNA in multiple brain regions in the brain of newborns, it will be interesting to explore the 
consequences of Nrg4 deletion more widely in the developing brain. 
  
3.4. Neocortical neurons cultured from Nrg4
-/-
 embryos have stunted dendrites and axons 
To ascertain whether the dendrite phenotype observed in developing Nrg4
-/-
 mice in vivo 
is replicated in vitro and can be rescued by NRG4 treatment, we set up dissociated neocortical 
cultures from Nrg4
-/-
 and Nrg4
+/+
 littermates.  Cultures were established from the E16 cerebral 
cortex, a stage at which the predominant neuron type in culture is the pyramidal neuron, as 
shown by staining our cultures for Emx1, a homeodomain protein that is specifically expressed 
by pyramidal neurons in the developing cerebral cortex (Chan et al., 2001). More than 80% cells 
in our cultures were positive for Emx1 after 3 days in culture. An added advantage of studying 
cultured pyramidal neurons is that dendrites and axons can be distinguished and studied 
separately (Banker and Cowan, 1979; Dotti et al., 1988; Kaech and Banker, 2006).  After 3 days 
in culture, the single long axon that emerges from these neurons is clearly distinguishable from 
the multiple, short dendrites. After 9 days in culture, the axon remains the longest process and 
MAP-2-positive dendrites become well-developed. 
Pyramidal neurons cultured from Nrg4
-/-
 mice were clearly smaller and less branched 
compared with those cultured from Nrg4
+/+
 littermates in both 3 day and 9 day cultures (Fig. 5A).  
Quantification of axon length and total dendrite length in the arbors of individual pyramidal 
neurons revealed significant reductions in axon and dendrite length in neurons cultured from 
Nrg4
-/-
 mice compared with those cultured from Nrg4
+/+
 littermates (Figs. 5B and 5C). 
Quantification of the number of branch points in the dendrite arbors of 9 day cultures also 
revealed a significant reduction in cultures established from Nrg4
-/-
 mice compared with Nrg4
+/+
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littermates (Fig. 5D).  The differences in the size and complexity of neurite arbors of neurons 
cultured from Nrg4
-/-
 and Nrg4
+/+
 littermates were reflected in the Sholl plots of these neurons 
(Fig. 5E), which provide graphic illustrations of neurite length and branching with distance from 
the cell body.  The reductions in axon and dendrite length and dendrite branching in pyramidal 
neurons cultured from Nrg4
-/-
 mice were completely restored to wild type levels by treatment 
with recombinant NRG4 (Fig. 5).  
These results show that the pyramidal neuron phenotype observed in vivo in NRG4-
deficient mice is replicated in cultured neurons and is rescued by soluble NRG4.   Our findings 
also raise the possibility that NRG4 plays a role in regulating the growth of pyramidal axons as 
well as being required for the growth and branching of pyramidal dendrites.  However, because 
the full extent of pyramidal neuron axons cannot be reliably discerned in Golgi preparations, we 
cannot definitively conclude that NRG4 enhances the growth of pyramidal axons in vivo.   
Although we have shown that recombinant NRG4 rescues the stunted phenotype of neocortical 
pyramidal neurons cultured from Nrg4
-/-
 mice, we cannot exclude the possibility that the 
metabolic changes that occur in these mice (Chen et al., 2017; Wang et al., 2014) contributes to 
the development of the in vivo phenotype that we observed in the neocortex. 
 
3.5. Neocortical pyramidal neurons co-express NRG4 and ErbB4 
To ascertain the identity of the cells that produce NRG4 in neocortex, we studied NRG4 
immunofluorescence in cortical sections and dissociated cortical cultures.  In sections of the 
neocortex of P10 mice, NRG4 immunoreactivity was observed throughout the cortex (Fig. 6A).  
In dissociated cultures of E16 cortical cultures, double labeling for NRG4 and the pyramidal 
neuron marker Emx1 revealed that 82.1 ± 2.3% of the Emx1-positive cells were co-labeled with 
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anti-NRG4 after 3 days in vitro.  NRG4 immunoreactivity was not observed in cultures 
established from Nrg4
-/-
 mice, demonstrating the specificity of the anti-NRG4 antibody (Fig. 6B). 
The majority of Emx1-positive cells were also co-labeled with antibodies to ErbB4, the principal 
NRG4 receptor (Fig. 6C).  While ErbB4 is abundantly expressed by neocortical and hippocampal 
GABAergic interneurons (Chen et al., 2010b; Fazzari et al., 2010), lower levels of ErbB4 have 
been convincingly demonstrated in pyramidal neurons of the neocortex and hippocampus. For 
example, ErbB4 immunoreactivity is observed in a subset of CamKII-positive cortical pyramidal 
neurons, staining which is eliminated in mice with conditional deletion of ErbB4 in the brain 
(Cooper and Koleske, 2014). 
The above observations suggest that the majority of embryonic cortical neurons co-
express NRG4 and ErbB4.  To formally demonstrate co-expression, we double labeled E16 
cortical cultures with antibodies to NRG4 and ErbB4 (Fig. 6D).  80.3 ± 5.5% of the cells 
exhibiting a neuronal morphology were double labeled with these antibodies.  This finding 
increases our confidence that many cortical pyramidal neurons co-express NRG4 and ErbB4, at 
least in culture, and raises the possibility that NRG4 exerts its effects on pyramidal neurons in 
vivo at least in part by an autocrine/paracrine mechanism.  NRG1 autocrine/paracrine signaling 
has been shown to promote remyelination following peripheral nerve injury (Stassart et al., 
2013) and an ErbB4/NRG2 autocrine signaling loop has been demonstrated in inhibitory 
interneurons (Vullhorst et al., 2015).  Neuregulin autocrine signaling has also been implicated 
outside the nervous system, for example, in promoting the proliferation of certain cancers (Sheng 
et al., 2010).  In future work, it will be interesting to ascertain how the putative NRG4/ErbB4 
autocrine loop is regulated in pyramidal neurons, which will provide us with a better 
understanding of why it is employed in developing brain. 
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Our demonstration that NRG4 is a major physiologically relevant regulator of the growth 
and elaboration of pyramidal neuron dendrites in the developing neocortex raises a host of 
important questions for future work, especially what are behavioural consequences of the major 
cellular phenotype observed in NRG4-deficient mice and whether NRG4 contributes to the 
pathogenesis of particular neurological disorders. Given the widespread expression of NRG4 in 
brain, it will be interesting to investigate whether the lack of NRG4 elsewhere in the brain affects 
other neurons or circuits and whether axons are affected in addition to dendrites. 
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Figure legends 
Figure 1.  Nrg4 mRNA is expressed in the developing brain. Levels of Nrg4 mRNA in the 
neocortex at different ages compared with adult brown adipose tissue (BAT) (A) and in different 
brain regions at P0 (B) and the levels of ErbB4 mRNA in these regions (C) relative to the 
geometric mean of reference mRNAs. The mean ± s.e.m. of data from four separate sets of 
tissues at each age/region are plotted.  
 
Figure 2. Phenotypic changes in neocortical pyramidal neurons of Nrg4
-/-
 P10 mice. (A) 
Representative low-power and high-power images of Golgi preparations of the motor neocortex 
of P10 Nrg4
+/+
 and Nrg4
-/-
 mice. Scale bar = 50m. Quantification of total dendrite length (B) 
and number of branch points (C) in the apical and basal dendrite compartments of pyramidal 
neurons in the motor neocortices of P10 Nrg4
+/+
 and Nrg4
-/-
 littermates.  Sholl plots of the apical 
(D) and basal (E) dendrite compartments of these neurons. The mean ± s.e.m. of data from 90 
neurons per genotype are plotted (*P < 0.05, **P < 0.01, ****P < 0.0001, statistical comparison 
between Nrg4
+/+
 and Nrg4
-/-
 mice, two-tailed t-test). 
 
Figure 3. Phenotypic changes in neocortical pyramidal neurons of Nrg4
-/-
 P30 mice. 
(A) Representative low-power and high-power images of Golgi preparations of the motor 
neocortex of P30 Nrg4
+/+
 and Nrg4
-/-
 mice. Scale bar = 50m. Quantification of total dendrite 
length (B) and number of branch points (C) in the apical and basal dendrite compartments of 
pyramidal neurons in the motor neocortices of P30 Nrg4
+/+
 and Nrg4
-/-
 littermates.  Sholl plots of 
the apical (D) and basal (E) dendrite compartments of these neurons. The mean ± s.e.m. of data 
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from 20 neurons per genotype are plotted (ns, not significant, ***P < 0.001, ****P < 0.0001, 
statistical comparison between Nrg4
+/+
 and Nrg4
-/-
 mice, two-tailed t-test).  
 
Figure 4. Neocortical pyramidal neurons of Nrg4
-/-
 and Nrg4
+/+
 adult mice.  Representative 
low-power and high-power images of Golgi preparations of the motor neocortex of adult (P60 
and P70) Nrg4
+/+
 and Nrg4
-/-
 mice. Four cortices of each genotype were examined (3 P60 Nrg4
+/+
, 
3 P60 Nrg4
-/-
, 1 P70 Nrg4
+/+
, 1 P70 Nrg4
-/-
).  Scale bar = 50m. 
 
Figure 5.  Nrg4 enhances dendrite growth from cultured cortical pyramidal neurons. (A) 
Representative photomicrographs of cortical neurons of Nrg4
+/+
 and Nrg4
-/-
 E16 embryos 
cultured for either 3 or 9 days in culture.  Neurons from Nrg4
-/-
 embryos were additionally 
treated with recombinant 100 ng/ml NRG4. Scale bar = 25m. Quantification of total neurite 
length in these cultures after either 3 days (B) or 9 days (C) in vitro and the number of branch 
points after 9 days in vitro (D). Sholl plots of neurons after 9 days in vitro (E). Mean ± s.e.m of 
data collected from three independent experiments, *p<0.01, and **p<0.0001, one-way ANOVA 
with Holme-Sidak’s multiple comparison post-hoc test. 
 
Figure 6.  Developing neocortical pyramidal neurons co-express NRG4 and ErbB4. (A) 
Representative section of the motor neocortex of P10 mice double labelled with antibodies to 
NRG4 and MAP2.  Scale bar = 50 m. Representative photomicrographs of neocortical neurons 
of E16 embryos cultured for 3 days and double labelled with antibodies to either NRG4 and 
Emx1 (B), ErbB4 and Emx1 (C) or NRG4 and ErbB4 (D).  To demonstrate the specificity of the 
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anti-NRG4 antibody, cultures were set up from E16 Nrg4
-/-
 embryos, which eliminated NRG4 
but not Emx1 immunoreactivity (B). Scale bars = 10m. 
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Highlights 
 First evidence that neuregulin-4 (NRG4) functions in the nervous system. 
 Neocortical pyramidal dendrites are markedly stunted in Nrg4-/- neonates. 
 Compensatory changes occur in the pyramidal dendrites of Nrg4-/- mice with age. 
 Neurons cultured from Nrg4-/- embryos replicated the in vivo phenotype. 
 Recombinant NRG4 rescued the stunted dendrite phenotype of these neurons. 
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